Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia

por van der Veer, A, van der Velden, V H J, Willemse, M E, Hoogeveen, P G, Petricoin, E F, Beverloo, H B, Escherich, G, Horstmann, M A, Pieters, R, den Boer, M L
Publicado 2014